留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝移植术后急性肾损伤的诊断与治疗

蔡金贞, 李志强, 许传屾, 等. 肝移植术后急性肾损伤的诊断与治疗[J]. 器官移植, 2023, 14(4): 473-478. doi: 10.3969/j.issn.1674-7445.2023.04.001
引用本文: 蔡金贞, 李志强, 许传屾, 等. 肝移植术后急性肾损伤的诊断与治疗[J]. 器官移植, 2023, 14(4): 473-478. doi: 10.3969/j.issn.1674-7445.2023.04.001
Cai Jinzhen, Li Zhiqiang, Xu Chuanshen, et al. Diagnosis and treatment of acute kidney injury after liver transplantation[J]. ORGAN TRANSPLANTATION, 2023, 14(4): 473-478. doi: 10.3969/j.issn.1674-7445.2023.04.001
Citation: Cai Jinzhen, Li Zhiqiang, Xu Chuanshen, et al. Diagnosis and treatment of acute kidney injury after liver transplantation[J]. ORGAN TRANSPLANTATION, 2023, 14(4): 473-478. doi: 10.3969/j.issn.1674-7445.2023.04.001

肝移植术后急性肾损伤的诊断与治疗

doi: 10.3969/j.issn.1674-7445.2023.04.001
基金项目: 

山东省自然科学基金 ZR2022MH292

山东省学校卫生协会2022年度科研课题 SDWS2022070

青岛大学医学部“临床医学+X”工程科研项目 2017225

青岛大学附属医院“临床医学+X”科研项目 QYFY+X202101060

详细信息
    作者简介:
    通讯作者:

    蔡金贞(ORCID:0000-0001-5414-1050),Email:caijinzhen@sina.comCai

  • 中图分类号: R617, R692

Diagnosis and treatment of acute kidney injury after liver transplantation

More Information
  • 摘要: 急性肾损伤是肝移植术后常见的并发症,严重影响肝移植受者的预后。肝移植术前、术中和术后的多种因素均可引起肾损伤,如未进行妥善处理,可进展为慢性肾病,显著增加术后病死率,对肝移植的临床疗效产生负面影响。因此,肝移植术后急性肾损伤的预防、诊断及治疗是临床医师研究的热点。本文从急性肾损伤的定义,肝移植术后急性肾损伤的诊断、危险因素、预防及处理等几个方面进行综述,探讨肝移植术后急性肾损伤发生发展的各个阶段可能存在的危险因素及相关治疗策略,旨在通过优化治疗方案,降低肝移植术后急性肾损伤的风险,进一步改善肝移植受者的临床预后。

     

  • 表  1  根据KDIGO定义的AKI分级

    Table  1.   Staging criteria of AKI defined by KDIGO

    AKI分级 标准
    1级 Scr≥1.5倍基线值或任意48 h内升高0.3 mg/dL,或尿量 < 0.5 mL/kg持续6~12 h
    2级 Scr≥2倍基线值或尿量 < 0.5 mL/kg持续超过12 h
    3级 Scr≥3倍基线值或增加至4.0 mg/dL或行紧急透析,或尿量 < 0.3 mL/kg持续超过24 h
    注:①1 mg/dL=88.4 μmol/L。
    下载: 导出CSV
  • [1] ZENG J, LI Q, WU Q, et al. A novel online calculator predicting acute kidney injury after liver transplantation: a retrospective study[J]. Transpl Int, 2023, 36: 10887. DOI: 10.3389/ti.2023.10887.
    [2] LEE YS, CHOI YJ, PARK KH, et al. Liver transplant patients with high levels of preoperative serum ammonia are at increased risk for postoperative acute kidney injury: a retrospective study[J]. J Clin Med, 2020, 9(6): 1629. DOI: 10.3390/jcm9061629.
    [3] 庄震, 李月红. 肝移植相关肾损伤[J]. 临床内科杂志, 2021, 38(3): 152-154. DOI: 10.3969/j.issn.1001-9057.2021.03.003.

    ZHUANG Z, LI YH. Liver transplant-related kidney injury[J]. J Clin Intern Med, 2021, 38(3): 152-154. DOI: 10.3969/j.issn.1001-9057.2021.03.003.
    [4] LEWANDOWSKA L, MATUSZKIEWICZ-ROWINSKA J. Acute kidney injury after procedures of orthotopic liver transplantation[J]. Ann Transplant, 2011, 16(2): 103-108. DOI: 10.12659/aot.881872.
    [5] RONCO C, BELLOMO R, KELLUM JA. Acute kidney injury[J]. Lancet, 2019, 394(10212): 1949-1964. DOI: 10.1016/S0140-6736(19)32563-2.
    [6] 张宇, 王宝娟. 肾小球滤过率估算公式的适用性研究进展[J]. 临床医学研究与实践, 2023, 8(8): 191-194. DOI: 10.19347/j.cnki.2096-1413.202308056.

    ZHANG Y, WANG BJ. Research progress on the applicability of estimating formula of glomerular filtration rate[J]. Clin Res Pract, 2023, 8(8): 191-194. DOI: 10.19347/j.cnki.2096-1413.202308056.
    [7] FRANCOZ C, NADIM MK, BARON A, et al. Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations[J]. Hepatology, 2014, 59(4): 1514-1521. DOI: 10.1002/hep.26704.
    [8] KALAFATELI M, WICKHAM F, BURNISTON M, et al. Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: the royal free hospital cirrhosis glomerular filtration rate[J]. Hepatology, 2017, 65(2): 582-591. DOI: 10.1002/hep.28891.
    [9] FRANCOZ C, NADIM MK, DURAND F. Kidney biomarkers in cirrhosis[J]. J Hepatol, 2016, 65(4): 809-824. DOI: 10.1016/j.jhep.2016.05.025.
    [10] RODRIGUES CE, ENDRE ZH. Definitions, phenotypes, and subphenotypes in acute kidney injury-moving towards precision medicine[J]. Nephrology (Carlton), 2023, 28(2): 83-96. DOI: 10.1111/nep.14132.
    [11] CHRISTIADI D, SIMPSON C, O'BRIEN K, et al. Cystatin C kidney functional reserve: a simple method to predict outcome in chronic kidney disease[J]. Nephrol Dial Transplant, 2022, 37(6): 1118-1124. DOI: 10.1093/ndt/gfab188.
    [12] LIMA C, DE PAIVA HADDAD LB, DE MELO PDV, et al. Early detection of acute kidney injury in the perioperative period of liver transplant with neutrophil gelatinase-associated lipocalin[J]. BMC Nephrol, 2019, 20(1): 367. DOI: 10.1186/s12882-019-1566-9.
    [13] 刘琪, 张翔宇, 郑嘉奕. 肝移植术后急性肾损伤的发生情况、危险因素与预后分析[J]. 实用中西医结合临床, 2022, 22(17): 83-86. DOI: 10.13638/j.issn.1671-4040.2022.17.024.

    LIU Q, ZHANG XY, ZHENG JY. Analysis of the incidence, risk factors, and prognosis of acute kidney injury after liver transplantation[J]. Pract Clin J Integr Tradit Chin West Med, 2022, 22(17): 83-86. DOI: 10.13638/j.issn.1671-4040.2022.17.024.
    [14] 韩悦, 郭书琰, 韩玉珍, 等. 肝移植术后早期与晚期急性肾损伤的危险因素[J]. 中国急救医学, 2021, 41(3): 201-205. DOI: 10.3969/j.issn.1002-1949.2021.03.004.

    HAN Y, GUO SY, HAN YZ, et al. Analysis of risk factors for early and late acute kidney injury after liver transplantation[J]. Chin J Crit Care Med, 2021, 41(3): 201-205. DOI: 10.3969/j.issn.1002-1949.2021.03.004.
    [15] SANCHEZ EQ, GONWA TA, LEVY MF, et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation[J]. Transplantation, 2004, 78(7): 1048-1054. DOI: 10.1097/01.tp.0000137176.95730.5b.
    [16] GAO SL, MOU BY, DAI DS, et al. Marginal donor liver versus standard donor liver: a single center-observational study[J]. Hepatobiliary Pancreat Dis Int, 2023, 22(3): 239-244. DOI: 10.1016/j.hbpd.2022.10.005.
    [17] CHO H, BAE J, YOON HK, et al. Perioperative ABO blood group isoagglutinin titer and the risk of acute kidney injury after ABO-incompatible living donor liver transplantation[J]. J Clin Med, 2021, 10(8): 1679. DOI: 10.3390/jcm10081679.
    [18] ZHANG D, LIU Z, BI JF, et al. Risk factors for the incidence and severity of acute kidney injury after liver transplantation[J]. Turk J Gastroenterol, 2021, 32(1): 82-87. DOI: 10.5152/tjg.2020.19592.
    [19] FIORELLI S, BIANCOFIORE G, FELTRACCO P, et al. Acute kidney injury after liver transplantation, perioperative risk factors, and outcome: prospective observational study of 1681 patients (OLTx study)[J]. Minerva Anestesiol, 2022, 88(4): 248-258. DOI: 10.23736/S0375-9393.21.15860-2.
    [20] ZHOU J, ZHANG X, LYU L, et al. Modifiable risk factors of acute kidney injury after liver transplantation: a systematic review and meta-analysis[J]. BMC Nephrol, 2021, 22(1): 149. DOI: 10.1186/s12882-021-02360-8.
    [21] XIN W, YI W, LIU H, et al. Early prediction of acute kidney injury after liver transplantation by scoring system and decision tree[J]. Ren Fail, 2021, 43(1): 1137-1145. DOI: 10.1080/0886022X.2021.1945462.
    [22] NADEEM A, SALAHUDDIN N, EL HAZMI AJ, et al. Chloride-liberal fluids are associated with acute kidney injury after liver transplantation[J]. Crit Care, 2014, 18(6): 625. DOI: 10.1186/s13054-014-0625-7.
    [23] BOTEON YL, BOTEON APCS. Impact of graded donor liver steatosis on ischemia-reperfusion injury after liver transplantation: where are we now?[J]. J Clin Exp Hepatol, 2021, 11(1): 157-158. DOI: 10.1016/j.jceh.2020.06.007.
    [24] HIRAO H, NAKAMURA K, KUPIEC-WEGLINSKI JW. Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(4): 239-256. DOI: 10.1038/s41575-021-00549-8.
    [25] NASTOS C, KALIMERIS K, PAPOUTSIDAKIS N, et al. Global consequences of liver ischemia/reperfusion injury[J]. Oxid Med Cell Longev, 2014: 906965. DOI: 10.1155/2014/906965.
    [26] CEZAR LC, MENESES GC, DA SILVA JUNIOR GB, et al. Intraoperative systemic biomarkers predict post-liver transplantation acute kidney injury[J]. Eur J Gastroenterol Hepatol, 2021, 33(12): 1556-1563. DOI: 10.1097/MEG.0000000000001892.
    [27] 庄莉, 刘相艳. 肝移植受者围手术期管理及并发症预防与治疗[J]. 中华消化外科杂志, 2021, 20(10): 1037-1041. DOI: 10.3760/cma.j.cn115610-20210915-00459.

    ZHUANG Y, LIU XY. Perioperative management and complications prevention and treatment of recipients in liver transplantation[J]. Chin J Dig Surg, 2021, 20(10): 1037-1041. DOI: 10.3760/cma.j.cn115610-20210915-00459.
    [28] DONG V, NADIM MK, KARVELLAS CJ. Post-liver transplant acute kidney injury[J]. Liver Transpl, 2021, 27(11): 1653-1664. DOI: 10.1002/lt.26094.
    [29] 白明传, 毛慧娟. 肝移植术后急性肾损伤的研究新进展[J]. 临床肾脏病杂志, 2020, 20(12): 996-1002. DOI: 10.3969/j.issn.1671-2390.2020.12.012.

    BAI MC, MAO HJ. Acute kidney injury after liver transplantation: recent view and future forecast[J]. J Clin Nephrol, 2020, 20(12): 996-1002. DOI: 10.3969/j.issn.1671-2390.2020.12.012.
    [30] SAKAI T. Acute kidney injury after adult liver transplantation-doesn't intraoperative management matter?[J]. Liver Transpl, 2022, 28(7): 1131-1132. DOI: 10.1002/lt.26469.
    [31] SMOTER P, NYCKOWSKI P, GRAT M, et al. Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience[J]. Transplant Proc, 2014, 46(8): 2786-2789. DOI: 10.1016/j.transproceed.2014.09.044.
    [32] 邓攀, 赵于军, 王强, 等. 肝移植术后并发急性肾损伤的诊疗进展[J/CD]. 中华移植杂志(电子版), 2020, 14(1): 44-48. DOI: 10.3877/cma.j.issn.1674-3903.2020.01.012.

    DENG P, ZHAO YJ, WANG Q, et al. Progress of diagnosis and treatment of acute kidney injury after liver transplantation[J/CD]. Chin J Transplant (Electr Edit), 2020, 14(1): 44-48. DOI: 10.3877/cma.j.issn.1674-3903.2020.01.012.
    [33] LAMEIRE NH, LEVIN A, KELLUM JA, et al. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference[J]. Kidney Int, 2021, 100(3): 516-526. DOI: 10.1016/j.kint.2021.06.028.
    [34] JIA JJ, ZHANG SY, YU J, et al. The immune profiles and "minimizing tacrolimus" strategy for long-term survival recipients after liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2021, 20(2): 190-192. DOI: 10.1016/j.hbpd.2020.08.004.
    [35] HASHIM M, ALSEBAEY A, RAGAB A, et al. Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: a single center study[J]. Ann Hepatol, 2020, 19(5): 541-545. DOI: 10.5604/01.3001.0012.2246.
    [36] ASRANI SK, WIESNER RH, TROTTER JF, et al. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase Ⅱ prospective randomized trial[J]. Am J Transplant, 2014, 14(2): 356-366. DOI: 10.1111/ajt.12543.
    [37] FISCHER L, KLEMPNAUER J, BECKEBAUM S, et al. A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation—PROTECT[J]. Am J Transplant, 2012, 12(7): 1855-1865. DOI: 10.1111/j.1600-6143.2012.04049.x.
    [38] 刘子希, 朱继巧, 马军, 等. 肝移植术后免疫抑制剂的减药方案临床研究进展[J]. 器官移植, 2019, 10(3): 328-332. DOI: 10.3969/j.issn.1674-7445.2019.03.018.

    LIU ZX, ZHU JQ, MA J, et al. Clinical research progress of drug-reducing regimen for immunosuppressants after liver transplantation[J]. Organ Transplant, 2019, 10(3): 328-332. DOI: 10.3969/j.issn.1674-7445.2019.03.018.
    [39] STARRT-AKI Investigators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, et al. Timing of initiation of renal-replacement therapy in acute kidney injury[J]. N Engl J Med, 2020, 383(3): 240-251. DOI: 10.1056/NEJMoa2000741.
    [40] REN A, LI Z, ZHANG X, et al. Optimal timing of initiating CRRT in patients with acute kidney injury after liver transplantation[J]. Ann Transl Med, 2020, 8(21): 1361. DOI: 10.21037/atm-20-2352.
  • 加载中
图(1) / 表(1)
计量
  • 文章访问数:  431
  • HTML全文浏览量:  84
  • PDF下载量:  84
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-04-30
  • 网络出版日期:  2023-07-13
  • 刊出日期:  2023-07-15

目录

    /

    返回文章
    返回